Derivative exercise or conversion — not an open-market buy.
Loading…
Planned for Aug 6, 2026 · Notice filed Aug 6, 2026
A top manager at Johnson & Johnson told the SEC they plan to sell $4.09M of Johnson & Johnson shares around Aug 6, 2026. The shares came from their pay, which is the usual reason to sell.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
None found in footnotes
Only flagged when a footnote says so; never inferred
Derivative exercise or conversion — not an open-market buy.
37K → 25K shares held−30% of their stake
Johnson & Johnson's WW Chair, MedTech sold $3.04M of Johnson & Johnson shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.